Two years ago Avantor Performance Materials was headquartered in the aging New Jersey building it had occupied for half a century, with some of its people working in office trailers and others at a remote site miles away. Today, relocated to Upper Saucon Township's Stabler Corporate Center, the specialty-chemical maker is positioned to capitalize on its expertise serving the growing pharmaceutical and biotechnology industries and manage a global network of research and production facilities from the Lehigh Valley. "I really do think we have the infrastructure here to manage a company twice our size," said President and CEO John Steitz, who took over leadership of the...

Related "Amgen Inc." Articles

Two years ago Avantor Performance Materials was headquartered in the aging New Jersey building it had occupied for half a century, with some of its people working in office trailers and others at a remote site miles away.
Today, relocated to Upper Saucon...

Cedar Crest's Lizzy Sunderhaus has been named as one of 11 national women finalists for the 2011 Jostens Trophy, as announced by the Rotary Club of Salem, VA. The Jostens Trophy, publicized by the Old Dominion Athletic Conference (ODAC), is ...

U.S. regulators are likely to approve Merck & Co's highly anticipated immuno-oncology drug, pembrolizumab, as a treatment for melanoma well ahead of a late October deadline, according to three sources familiar with the situation. If approved by the...

Miramax Chairman Richard Nanula has taken a leave of absence from the Santa Monica independent film studio and from its co-owner Colony Capital, where he is also a principal.
The disclosure of Nanula's departure Wednesday came after two websites recently...

After being spurned two months ago, biotech giant Amgen Inc. said it has reached a $10.4-billion deal for Onyx Pharmaceuticals Inc., which has developed a promising drug to fight blood cancer.
Amgen, based in Thousand Oaks, will pay $125 per share for...

WASHINGTON -- The U.S. will run out of borrowing authority under the nation's $16.7-trillion debt limit in mid-October, Treasury Secretary Jacob J. Lew formally told Congress on Monday as he implored lawmakers to act soon to avoid a government default.
...

Members of an experimental class of cholesterol-lowering drugs could get U.S. regulatory approval based on their ability to lower "bad" cholesterol, and may not need to show that they reduce the risk of heart attack and stroke, the Food and Drug...

NEW YORK (Reuters Health) - Hormone-targeted therapy for prostate cancer may raise the risk of potentially dangerous blood clots, a large U.S. study suggests.
Analyzing data on more than 154,000 older men with prostate cancer, researchers found that...

Bonnie Addario didn't even know there was a word for what was happening to her. As if lung cancer weren't bad enough, the 54-year-old had lost 30 pounds off her normally 130-pound frame. Her life was limited to her husband's Barcalounger, where she had to...

The U.S. Food and Drug Administration recently approved a new drug for osteoporosis. Amgen's Prolia (denosumab) prevents fractures in postmenopausal women at a rate similar to the most popular drugs on the market — bisphosphonates such as Fosamax,...